Explanatory Indicators Sample Clauses

Explanatory Indicators. Without limiting the definition of “Explanatory Indicator” set out in s. 1.1, Explanatory Indicators: • are complementary indicators to the Accountability Indicators and will be documented in the technical specifications of the most appropriate Accountability Indicator(s); • support planning, negotiation or problem-solving at the provincial, LHIN level or agency level; • support transparency and enable planning discussions; • support of improving and sustaining health system quality, effectiveness and efficiency; • are indicators where data may already be provided through existing reporting systems; and • will not trigger consequences under the SAA (unless otherwise specified in a Performance Improvement Plan or new funding obligations). Turnover Rate is an example of an Explanatory Indicator. Schedule E1 CORE INDICATORS- All Sectors Healthcare Service Provider: Xxxxxx Xxxxx Memorial Hospital Accountability Indicators 2011-2012 2012-2013 2013-2014 Target Performance Standard Target Performance Standard Target Performance Standard % Total Margin -1% >=0% 0% >=0% XXX XXX Fund Type 2- Balanced Budget 0 0 0 0 XXX XXX Proportion of Budget Spent on Administration 0% < 0% 0% < 0% XXX XXX Variance Forecast to Actual Expenditures 0.0% < 5% 0.0% < 5% XXX XXX Variance Forecast to Actual Units of Service 0.0% < 5% 0.0% < 5% XXX XXX Explanatory Indicators Cost per Unit Service (by Functional Centre) Cost per Individual Served (by program/service) Turnover Rate Repeat Unplanned Emergency Visits within 30 days - Mental Health Conditions Repeat Unplanned Emergency Visits within 30 days - Substance Abuse Conditions Percentage of Alternate Level of Care (ALC) days Schedule E2a CORE INDICATORS- All Sectors Healthcare Service Provider: Xxxxxx Xxxxx Memorial Hospital 2011-2012 2012-2013 2013-2014 OHRS Description Health Service Activity *FTE & Total Functional Centre Cost: These values are provided for information purposes only. They are not Accountability Indicators. Target Performance Standard Target Performance Standard Target Performance Standard COM Case Management - Mental Health 72 5 09 76 S 450*, 451*, 455* Full-time equivalents (FTE) S 310*,350*,380*,390* (Earned Hours) divided by 1950= FTE *1.6 N/A *1.6 N/A *TBD N/A COM Case Management - Mental Health 72 5 09 76 S 450*, 451*, 455* Visits Face-to-face, Telephone In-House, Contracted Out S 450*, 451*, 448*, 449* 1500 1350 - 1650 1500 1350 - 1650 XXX XXX COM Case Management - Mental Health 72 5 09 76 S 450*, 451*, 455* ...
Sample 1See All (9)
AutoNDA by SimpleDocs
Explanatory Indicators. Without limiting the definition of “Explanatory Indicator” set out in s. 1.1, Explanatory Indicators: • are complementary indicators to the Accountability Indicators and will be documented in the technical specifications of the most appropriate Accountability Indicator(s); • support planning, negotiation or problem-solving at the provincial, LHIN level or agency level; • support transparency and enable planning discussions; • support of improving and sustaining health system quality, effectiveness and efficiency; • are indicators where data may already be provided through existing reporting systems; and • will not trigger consequences under the SAA (unless otherwise specified in a Performance Improvement Plan or new funding obligations). Turnover Rate is an example of an Explanatory Indicator. Schedule E1 CORE INDICATORS- All Sectors
Sample 1Sample 2Sample 3
Explanatory Indicators. Without limiting the definition of “Explanatory Indicator” set out in s. 1.1, Explanatory Indicators: • are complementary indicators to the Accountability Indicators and will be documented in the technical specifications of the most appropriate Accountability Indicator(s); • support planning, negotiation or problem-solving at the provincial, LHIN level or agency level; • support transparency and enable planning discussions; • support of improving and sustaining health system quality, effectiveness and efficiency; • are indicators where data may already be provided through existing reporting systems; and • will not trigger consequences under the SAA (unless otherwise specified in a Performance Improvement Plan or new funding obligations). Turnover Rate is an example of an Explanatory Indicator. Supplemental: Schedule E1 CORE INDICATORS- All Sectors % Total Margin Fund Type 2- Balanced Budget Proportion of Budget Spent on Administration Variance Forecast to Actual Expenditures Variance Forecast to Actual Units of Service Cost per Unit Service (by Functional Centre) Cost per Individual Served (by program/service) Service Activity Indicators- All Sectors Supplemental: Schedule E2a Service Activity Indicators- All Sectors Healthcare Service Provider: Baycrest Centre for Geriatric Care Full-time equivalents (FTE) *4.20 N/A Individuals Served by Functional Centre N/A N/A Attendance Days Face-to-Face 6,000 5700 - 6300 Total Cost for Functional Centre *$307,561 N/A Supplemental Schedule E2d : CSS Specific Indicators Percentage ALC Days 15.0% <16.5% Average number of days waited for First Service (by functional centre) N/A N/A Explanatory Indicators Repeat Unscheduled Emergency Visits within 30 days for Mental Health Conditions Repeat Unscheduled Emergency Visits within 30 days for Substance Abuse Conditions Number of Persons Waiting for Service (by functional centre) LHIN Local Indicators- LHIN Specific Supple me ntal Schedule E3: LHIN Local Indicators Healthcare Service Provider: Baycrest Centre for Geriatric Care Number of Individuals served by Organization 922 784 - 1060 XXX LOCAL HEALTH INTEGRATION NETWORK (the “LHIN”) [Legal Name of the Health Service Provider] (the “HSP”)
Sample 1

Related to Explanatory Indicators

  • Regulatory Inspections Manufacturer will permit Rhythm or its agents to be present and participate in any visit or inspection by any Authority of the Facility (to the extent it relates in any way to any Product) or the Manufacturing Process. Manufacturer will give as much advance notice as reasonably possible to Rhythm of any such visit or inspection. Manufacturer will provide Rhythm with a copy of any report or other written communication * CONFIDENTIAL TREATMENT REQUESTED. OMITTED PORTIONS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. received from such Authority in connection with such visit or inspection, and any written communication received from any Authority relating to any Product, the Facility (if it relates to or affects the Development and/or Manufacture of Product) or the Manufacturing Process, within two (2) business days after receipt, and will consult with, and require approval from, Rhythm before responding to each such communication. Manufacturer will provide Rhythm with a copy of its final responses within five (5) business days after submission.

  • Commercialization Plan At such times as the JGC will deem appropriate, the JGC will direct the Parties to mutually prepare a Worldwide Commercialization Plan, and the JGC will review and approve such initial Worldwide Commercialization Plan. Thereafter, the JGC will have one or the other Party (or both) update the Worldwide Commercialization Plan each calendar year, and the JGC will review and approve any such update or any other amendment to the Worldwide Commercialization Plan. Notwithstanding anything in this CCPS Agreement to the contrary, the Parties acknowledge and agree that (i) Bluebird may decline to perform any Commercialization activity proposed to be conducted by Bluebird in the Worldwide Commercialization Plan (other than Manufacturing of Vectors and associated Payloads), and (ii) the Worldwide Commercialization Plan will not include, and Bluebird will have no obligation to perform, any such Commercialization activity that Bluebird has declined to perform, provided that once Bluebird has agreed to perform a Commercialization activity, it will be obligated to perform, and cannot decline to perform, such activity. In addition, either Party may request at any time that the JGC consider and approve other updates to the Worldwide Commercialization Plan. Further: (a) The JGC will set the required form and contents of the Worldwide Commercialization Plan. The Worldwide Commercialization Plan will reflect a singular marketing and sales approach worldwide, and will specify, among other things, the number of sales reps in the U.S. for each Party, allocation of regions in the U.S. for each Parties’ sales force, creation of marketing materials, planning for conferences, and other marketing activities. CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. (b) Neither Party (itself or by or through any others, including any Affiliates or Sublicensees) will take any material action regarding the Commercialization of Licensed Product unless described in the Worldwide Commercialization Plan or approved by the JGC. (c) All Commercialization of Licensed Product for U.S. Administration will be conducted under the supervision of the JGC and as part of the U.S. Development & Commercialization Program. (d) Celgene will have final decision making authority for all Commercialization activities worldwide, including timing of launch and pricing and the Worldwide Development Plan.

  • New Products You agree to comply with NASD Notice to Members 5-26 recommending best practices for reviewing new products.

  • Regulatory Issues 3.3.1 The Licensee shall be solely responsible for determining which jurisdictions they choose to market to and receive xxxxxx from. 3.3.2 The Licensee shall be responsible for determining the legality of accepting xxxxxx in whichever jurisdictions they choose to market to and receive xxxxxx from. 3.3.3 The Licensee shall indemnify UNITED for any reasonable legal costs, and fines that arise as a result of the Licensee choosing to accept xxxxxx from any jurisdiction that determines or has determined that Internet wagering is illegal.

  • Marketing Plan The MCOP shall submit an annual marketing plan to ODM including all planned activities for promoting membership in or increasing awareness of the MCOP. The marketing plan submission shall include an attestation by the MCOP that the plan is accurate and is not intended to mislead, confuse, or defraud the eligible individuals or ODM.

  • Product Changes Vocera shall have the right, in its absolute discretion, without liability to End User, to update to provide new functionality or otherwise change the design of any Product or to discontinue the manufacture or sale of any Product. Vocera shall notify End User at least 90 days prior to the delivery of any Product which incorporates a change that adversely affects form, fit or function (“Material Change”). Vocera shall also notify End User at least 90 days prior to the discontinuance of manufacture of any Product. Notification will be made as soon as reasonably practical for changes associated with regulatory or health and safety issues.

  • Third Party Websites The Service may contain or reference links to websites operated by third parties ("Third Party Websites"). These links are provided as a convenience only. Such Third Party Websites are not under our control. We are not responsible for the content of any Third Party Website or any link contained in a Third Party Website. We do not review, approve, monitor, endorse, warrant, or make any representations with respect to Third Party Websites, and the inclusion of any link in the Service, Debit Rewards Offers or any other services provided in connection with them is not and does not imply an affiliation, sponsorship, endorsement, approval, investigation, verification or monitoring by us of any information contained in any Third Party Website. In no event will we be responsible for the information contained in such Third Party Website or for your use of or inability to use such website. Access to any Third Party Website is at your own risk, and you acknowledge and understand that linked Third Party Websites may contain terms and privacy policies that are different from ours. We are not responsible for such provisions, and expressly disclaim any liability for them.

  • Regulatory Information (a) All the notaries at De Pinna LLP are regulated through the Faculty Office of the Archbishop of Canterbury. Its address is The Faculty Office, 0 Xxx Xxxxxxxxx, Xxxxxxxxxxx, Xxxxxx XX0X 0XX, its telephone: 000 0000 0000, and it can be reached by email at xxxxxxx.xxxxxx@0xxxxxxxxxxxx.xxx. It also has a website at xxx.xxxxxxxxxxxxx.xxx.xx. (b) We are required to comply with the rules of professional conduct and other regulatory arrangements of the Master of the Faculties, the sole regulator of notarial activities under the Legal Services Act 2007. Information about those rules and regulations may be found at xxxx://xxx.xxxxxxxxxxxxx.xxx.xx/notary/i-am-a-notary/notaries-rules-regulations/. (c) We comply with the Code of Practice published by the Master of the Faculties: xxxx://xxx.xxxxxxxxxxxxx.xxx.xx/notary/code-of-practice.

  • Marketing Plans Contractor and the Exchange recognize that Enrollees and other health care consumers benefit from efforts relating to outreach activities designed to increase heath awareness and encourage enrollment. The parties shall share marketing plans on an annual basis and with respect to periodic updates of material changes. The marketing plans of each of the Exchange and Contractor shall include proposed marketing approaches and channels and shall provide samples of any planned marketing materials and related collateral as well as planned, and when completed, expenses for the marketing budget. The Contractor shall include this information for both the Exchange and the outside individual market. The Exchange shall treat all marketing information provided under this Section as confidential information and the obligation of the Exchange to maintain confidentiality of this information shall survive termination or expiration of this Agreement.

  • THIRD PARTY WEBSITES AND CONTENT The Website contains (or you may be sent through the Website or the Company Services) links to other websites ("Third Party Websites") as well as articles, photographs, text, graphics, pictures, designs, music, sound, video, information, applications, software and other content or items belonging to or originating from third parties (the "Third Party Content"). Such Third Party Websites and Third Party Content are not investigated, monitored or checked for accuracy, appropriateness, or completeness by us, and we are not responsible for any Third Party Websites accessed through the Website or any Third Party Content posted on, available through or installed from the Website, including the content, accuracy, offensiveness, opinions, reliability, privacy practices or other policies of or contained in the Third Party Websites or the Third Party Content. Inclusion of, linking to or permitting the use or installation of any Third Party Website or any Third Party Content does not imply approval or endorsement thereof by us. If you decide to leave the Website and access the Third Party Websites or to use or install any Third Party Content, you do so at your own risk and you should be aware that our terms and policies no longer govern. You should review the applicable terms and policies, including privacy and data gathering practices, of any website to which you navigate from the Website or relating to any applications you use or install from the Website. Any purchases you make through Third Party Websites will be through other websites and from other companies, and Company takes no responsibility whatsoever in relation to such purchases which are exclusively between you and the applicable third party. Company reserves the right but does not have the obligation to:

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!